CIK 0001368514
- Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562590442
- Phone
- +1 201-478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- 4 Open-market buy Director bought 20,000 shares at $4.78 ($95,600)
- 4 Open-market buy VP, CFO bought 5,000 shares at $4.78 ($23,900)
- 4 Open-market buy Director bought 5,230 shares at $4.78 ($24,999)
- 4 Open-market sale 10% owner sold 8,591,160 shares
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market buy Director bought 5,813,954 shares at $2.15 ($12,500,001)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 5,813,954 shares at $2.15 ($12,500,001)
- 4 Open-market buy Director bought 25,000 shares at $2.15 ($53,750)
- 4 Open-market buy VP, CFO bought 6,500 shares at $2.15 ($13,975)
- 4 Open-market buy President and CEO bought 485,000 shares at $2.15 ($1,042,750)
- 4 Open-market buy EVP, CSO and CMO bought 10,000 shares at $2.15 ($21,500)
- 4 Option exercise President and CEO acquired 42,021 shares (option exercise)
- 4 Option exercise Director acquired 48,185 shares (option exercise)
- 4 Option exercise Director acquired 2,800 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 12 of 19 · 364 filings